Covid-19 roundup: FDA grants priority review to Roche's Actemra; WHO suspends UN supply of Covaxin — report
After more than 9 months after the WHO gave the all-clear on IL-6 drugs for use in patients with Covid-19, including Roche’s immunosuppressant and rheumatoid …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
